Erna Kristin

471 total citations
47 papers, 316 citations indexed

About

Erna Kristin is a scholar working on Economics and Econometrics, Infectious Diseases and Geriatrics and Gerontology. According to data from OpenAlex, Erna Kristin has authored 47 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Economics and Econometrics, 7 papers in Infectious Diseases and 6 papers in Geriatrics and Gerontology. Recurrent topics in Erna Kristin's work include Health Systems, Economic Evaluations, Quality of Life (8 papers), Pharmaceutical Economics and Policy (8 papers) and Pharmaceutical Practices and Patient Outcomes (6 papers). Erna Kristin is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (8 papers), Pharmaceutical Economics and Policy (8 papers) and Pharmaceutical Practices and Patient Outcomes (6 papers). Erna Kristin collaborates with scholars based in Indonesia, United States and Thailand. Erna Kristin's co-authors include Iwan Dwiprahasto, Surakameth Mahasirimongkol, Mardiati Nadjib, Rika Yuliwulandari, Sudigdo Sastroasmoro, Dwi Endarti, Yot Teerawattananon, Larisa H. Cavallari, Franciscus D. Suyatna and Nuanjun Wichukchinda and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Nutrition.

In The Last Decade

Erna Kristin

37 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erna Kristin Indonesia 10 65 44 44 39 37 47 316
Mónica Muñoz United States 14 40 0.6× 23 0.5× 48 1.1× 50 1.3× 17 0.5× 45 485
Ana Hidalgo‐Simon Netherlands 9 99 1.5× 22 0.5× 29 0.7× 35 0.9× 10 0.3× 15 355
Samantha Alvarez‐Madrazo United Kingdom 12 61 0.9× 33 0.8× 41 0.9× 18 0.5× 7 0.2× 19 508
Daisuke Koide Japan 10 47 0.7× 30 0.7× 55 1.3× 13 0.3× 14 0.4× 27 577
Sabrina W. Cole United States 10 88 1.4× 16 0.4× 52 1.2× 19 0.5× 12 0.3× 14 361
Xuezhi Hong China 10 103 1.6× 19 0.4× 21 0.5× 14 0.4× 12 0.3× 15 539
Névine Zariffa United States 14 67 1.0× 52 1.2× 60 1.4× 26 0.7× 7 0.2× 30 650
Mo Dimbil United States 6 46 0.7× 53 1.2× 20 0.5× 26 0.7× 4 0.1× 7 455
Anders Helldén Sweden 11 31 0.5× 39 0.9× 21 0.5× 62 1.6× 31 0.8× 23 417
Humaira Majeed Khan Pakistan 8 130 2.0× 19 0.4× 28 0.6× 14 0.4× 11 0.3× 30 350

Countries citing papers authored by Erna Kristin

Since Specialization
Citations

This map shows the geographic impact of Erna Kristin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erna Kristin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erna Kristin more than expected).

Fields of papers citing papers by Erna Kristin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erna Kristin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erna Kristin. The network helps show where Erna Kristin may publish in the future.

Co-authorship network of co-authors of Erna Kristin

This figure shows the co-authorship network connecting the top 25 collaborators of Erna Kristin. A scholar is included among the top collaborators of Erna Kristin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erna Kristin. Erna Kristin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kristin, Erna, et al.. (2024). Quality and potency of government-subsidized antibiotics in hospitals Jakarta, Indonesia. 3(1). 1–10. 1 indexed citations
2.
Kristin, Erna, et al.. (2024). The comparative effectiveness of first-line treatment EGFR TKIs in Asian lung cancer population: A systematic review and meta-analysis. Journal of Applied Pharmaceutical Science. 1 indexed citations
5.
Kristin, Erna, et al.. (2023). Evaluation of Antibiotic Use with Quantitative Methods in Hospitalization Pneumonia Patients at West Nusa Tenggara Hospital. JURNAL ILMU KEFARMASIAN INDONESIA. 21(2). 303–303.
6.
Kristin, Erna, et al.. (2023). Effectiveness of Wait Time Targets and Patient Satisfaction Feedback in Decreasing Wait Times for Prescription Services in an Outpatient Pharmacy. The Canadian Journal of Hospital Pharmacy. 77(1). 1 indexed citations
7.
Kristin, Erna, et al.. (2023). Risk prediction models on adverse drug reactions: A review. Pharmacy Education. 23(4). 11–15.
9.
Kristin, Erna, et al.. (2022). Exploring the Experiences and Needs of Patients With Type 2 Diabetes Mellitus in Sleman Regency, Yogyakarta, Indonesia: Protocol for a Qualitative Study. JMIR Research Protocols. 11(9). e37528–e37528. 1 indexed citations
10.
Kristin, Erna, et al.. (2022). Treatment Outcomes of Multidrug-Resistant Tuberculosis Patients in East Java, Indonesia. International Journal of Mycobacteriology. 11(3). 261–267. 9 indexed citations
11.
Yuliwulandari, Rika, Jae Gook Shin, Erna Kristin, et al.. (2021). Cost-effectiveness analysis of genotyping for HLA-B*15:02 in Indonesian patients with epilepsy using a generic model. The Pharmacogenomics Journal. 21(4). 476–483. 11 indexed citations
12.
Kristin, Erna, et al.. (2020). PCV23 Budget IMPACT Analysis of Sacubitril Valsartan for Heart Failure Treatment in Indonesia. Value in Health Regional Issues. 22. S30–S30. 1 indexed citations
13.
Nadjib, Mardiati, Joshua Nealon, Sri Rezeki Hadinegoro, et al.. (2019). Economic burden of dengue in Indonesia. PLoS neglected tropical diseases. 13(1). e0007038–e0007038. 31 indexed citations
14.
Kristin, Erna, et al.. (2018). Evaluasi Perencanaan dan Pengadaan Obat di Instalasi Farmasi RSUD Kefamenanu Kabupaten Timor Tengah Utara. Indonesian Journal of Biotechnology (Universitas Gadjah Mada). 7(4). 147–153. 8 indexed citations
15.
Dwiprahasto, Iwan, et al.. (2018). Evaluation Of Computerized Prescribing Order Entry (Cpoe) Implementation In Preventing Medication Error. International Journal Of Medical Science And Clinical Invention. 5(9). 4075–4081. 1 indexed citations
16.
Kristin, Erna, et al.. (2017). Economic evaluation of policy options for dialysis in end-stage renal disease patients under the universal health coverage in Indonesia. PLoS ONE. 12(5). e0177436–e0177436. 46 indexed citations
17.
Kristin, Erna, et al.. (2016). DECREASE OF LIVER FUNCTION AFTER TREATMENT OF ANTITUBERCULOSIS DRUGS IN TUBERCULOSIS PATIENTS WITH MALNUTRITION AND ALCOHOL CONSUMPTION. International Journal of Pharmacy and Pharmaceutical Sciences. 8(7). 269–273. 6 indexed citations
18.
Yuliwulandari, Rika, Erna Kristin, Syafrizal Syafrizal, et al.. (2016). NAT2 variants are associated with drug-induced liver injury caused by anti-tuberculosis drugs in Indonesian patients with tuberculosis. Journal of Human Genetics. 61(6). 533–537. 49 indexed citations
19.
Kristin, Erna, et al.. (2011). REDESIGN PELAYANAN FARMASI DENGAN METODE FAILURE MODE AND EFFECT ANALYSIS. Jurnal Perlindungan Tanaman Indonesia (Universitas Gadjah Mada). 14(2). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026